Results 241 to 250 of about 2,744,703 (304)

Late Complete Endograft Occlusion After Endovascular Aneurysm Repair Successfully Treated With Unilateral Endograft Relining and Femoro-femoral Bypass: A Case Report. [PDF]

Vasc Specialist Int
Suno K, Yamamoto M, Uchiyama H, Masuda T, Nishioka N, Naraoka S, Kurimoto Y.   +6 more
europepmc   +1 more source

Active side branch protection in provisional stenting: techniques, case-based insights, and practical considerations. [PDF]

AsiaIntervention
Wong B, Khialani B, Fairley S, Touma G, Ada C, Wu E, Harding S.   +6 more
europepmc   +1 more source

Intellectual property protection, legal awareness, and startup growth: evidence from Somalia. [PDF]

Front Sociol
Osman OA, Ahmed AA, Isak ML, Hussein FM.
europepmc   +1 more source

Expression of concern: Engineering Pseudomonas protegens Pf-5 for nitrogen fixation and its application to improve plant growth under nitrogen-deficient conditions. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

International perspectives on AI-driven pharmaceutical IP challenges. [PDF]

Front Digit Health
Wang GY, Hao JM, Chen JG.
europepmc   +1 more source

The 2026 EU-India free trade agreement: why it matters for global health and trade. [PDF]

Lancet Reg Health Eur
Berner-Rodoreda A, Parwani P, Rao C, André E, Fröschl G, Skordis J, Sharma S, Bassat Q, Atun R, Vainieri M, Farlow A, Tediosi F, Ravinetto R, Ismail KM, Renganathan E, de Ruijter A, Taylor T, Ooms G, Herrington E, Dabade G, Bärnighausen T, Perehudoff K.   +21 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Microbiome therapeutics and patent protection

Nature Biotechnology, 2020
Obtaining patent protection for microbiome therapeutics has been affected profoundly by the US Supreme Court decisions in Myriad and Mayo, which redefined the scope of which natural phenomena, including microbiome therapeutics, are patent eligible.
Mark J, FitzGerald, Erik J, Spek
openaire   +2 more sources

Patent protection and licensing in microfluidics

Lab on a Chip, 2014
Microfluidic devices offer control over low-volume samples in order to achieve high-throughput analysis, and reduce turnaround time and costs. Their efficient commercialisation has implications for biomedical sciences, veterinary medicine, environmental monitoring and industrial applications.
Ali K, Yetisen, Lisa R, Volpatti
openaire   +2 more sources